PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-5.69%
Negative revenue growth while 3141.T stands at 9.55%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-7.03%
Negative gross profit growth while 3141.T is at 10.66%. Joel Greenblatt would examine cost competitiveness or demand decline.
-15.27%
Negative EBIT growth while 3141.T is at 26.95%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-30.94%
Negative operating income growth while 3141.T is at 74.82%. Joel Greenblatt would press for urgent turnaround measures.
-15.78%
Negative net income growth while 3141.T stands at 40.00%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-15.82%
Negative EPS growth while 3141.T is at 39.81%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-15.82%
Negative diluted EPS growth while 3141.T is at 39.81%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.00%
Share reduction while 3141.T is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Reduced diluted shares while 3141.T is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-100.00%
Dividend reduction while 3141.T stands at 15.74%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-50.98%
Negative OCF growth while 3141.T is at 6601.67%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-113.96%
Negative FCF growth while 3141.T is at 897.75%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
34.87%
10Y revenue/share CAGR above 1.5x 3141.T's 0.41%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
34.87%
5Y revenue/share CAGR above 1.5x 3141.T's 0.41%. David Dodd would look for consistent product or market expansions fueling outperformance.
34.87%
3Y revenue/share CAGR above 1.5x 3141.T's 0.41%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
78.18%
Net income/share CAGR at 50-75% of 3141.T's 105.56%. Martin Whitman might question if the firm’s product or cost base lags behind.
78.18%
5Y net income/share CAGR at 50-75% of 3141.T's 105.56%. Martin Whitman might see a shortfall in operational efficiency or brand power.
78.18%
3Y net income/share CAGR 50-75% of 3141.T's 105.56%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
46.81%
10Y equity/share CAGR above 1.5x 3141.T's 3.66%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
46.81%
5Y equity/share CAGR above 1.5x 3141.T's 3.66%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
46.81%
3Y equity/share CAGR above 1.5x 3141.T's 3.66%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
5.76%
We show growth while 3141.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
1.70%
Asset growth well under 50% of 3141.T's 3.76%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
4.85%
1.25-1.5x 3141.T's 3.50%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-12.38%
We’re deleveraging while 3141.T stands at 5.29%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.